ITOCO Signs Agreement with ASOCANNABIS to Develop an Academic Curriculum on the Medical Use of Cannabis

Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Club
$299/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

TORONTO, ON / ACCESSWIRE / August 14, 2019 / ITOCO Inc. ("ITOCO" or the "Company") (OTC PINK:ITMC) today announced that its Colombian subsidiary, ITOCO BIOMED SAS (“ITOCO BIOMED") has signed an agreement (the "Agreement") with the ASOCIACION INTERNACIONAL DE INDUSTRIAS Y CULTIVADORES DEL CANNABIS (ASOCANNABIS) to jointly develop an academic curriculum on the medicinal use of cannabis.

Asocannabis is a national guild that oversees the ethical exercise of the medical profession in Colombia. (www.asocannabis.com)

“Developing proper scientific and medical use protocols for health practitioners and patients is critical to sustain the advancement of medical cannabis in Colombia and elsewhere" said Michael Paul, President & CEO of ITOCO Inc.

"ITOCO is proud to make this arrangement with ASOCANNABIS, which will include providing traceability of genetics for clients and patients, from a credible and trusted source of information and training on medical cannabis", added Mr. Paul.

Since closing this agreement and making several important strategic acquisitions this year, ITOCO has made considerable progress supporting and building out our operations on the ground in Colombia. We look forward to regularly updating our stakeholders on our progress.

ITOCO continues to build a world class team in Colombia, dedicated to advancing the Company's business interests, including cultivation, processing, research and development, partnerships and continued expansion.

International operations are a core component of our growth strategy and the company is working to integrate and enhance operations and product channels throughout Latin America, positioning them for sustainable, long-term shareholder value creation.

ABOUT ASOCANNABIS

Asocannabis is an entity made up of doctors, businessmen and activists from the Medical Cannabis sector of Colombia. Their experience in the development of management techniques and economic development models around the cannabis industry is recognized nationally and internationally.

Asocannabis was formed in order to help patients, communities and microentrepreneurs who want to be part of this industry in a responsible and social aspect towards Colombia and its people, through best practices.

The association has among its objectives providing advice on strategies cultivation and the marketing and development of products to less favored communities. In addition advice and direction will be given on legal forms and context as well as help to patients and users of medical cannabis in Colombia.

Asocannabis are pioneers in the development, study, cultivation, and education of the Colombian cannabis industry.

ABOUT ITOCO INC.

ITOCO’s mission is to be a global leader in processing, distributing, and producing medical cannabis in a compliant environmentally friendly manner. The ITOCO management team has many years combined experience in business management and execution, raising capital and public company governance. ITOCO INC. is quoted on the OTC Markets, symbol: ITMC.

Forward-Looking Statements

This release contains forward-looking statements. Forward-looking statements, without limitation, may contain the words believes, expects, anticipates, estimates, potential, intends, plans, hopes, or similar expressions. Forward-looking statements are not guarantees of future performance. They involve risks, uncertainties and assumptions and actual results could differ materially from those anticipated. Forward looking statements are based on the opinions and estimates of management at the date the statements are made, and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements.

CONTACT:

ITOCO INC.
Michael Paul
ir@itoco.net
+1 (905) 829-5000

SOURCE: ITOCO INC.



View source version on accesswire.com:
https://www.accesswire.com/555975/ITOCO-Signs-Agreement-with-ASOCANNABIS-to-Develop-an-Academic-Curriculum-on-the-Medical-Use-of-Cannabis

Comment On!

140
Upload limit is up to 1mb only
To post messages to your Socail Media account, you must first give authorization from the websites. Select the platform you wish to connect your account to CanadianInsider.com (via Easy Blurb).